Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ B4GALNT3 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA552830
Description
Immunogen sequence: ETHNKCFYQE NAYYQDRFSF QEYIKIDQPE KQGLEQPGFE ENLLEESQYG EVAEETPASN NQNARMLEGR QTPASTLEQD ATDYRLRSLR KLLAQPREGL LAPFSKRNST ASFPGRTSHI PVQQPEKRKQ KPSPEPSQDS PHSD Highest antigen sequence identity to the following orthologs: Mouse - 60%, Rat - 57%.
Transfers N-acetylgalactosamine (GalNAc) from UDP-GalNAc to N-acetylglucosamine-beta-benzyl with a beta-1,4-linkage to form N,N'-diacetyllactosediamine, GalNAc-beta-1,4-GlcNAc structures in N-linked glycans and probably O-linked glycans. Mediates the N,N'- diacetyllactosediamine formation on gastric mucosa.
Specifications
B4GALNT3 | |
Polyclonal | |
Unconjugated | |
B4GALNT3 | |
B4GalNAcT3; B4GALNT3; beta-1,4-N-acetyl-galactosaminyl transferase 3; beta-1,4-N-acetylgalactosaminyltransferase 3; beta-1,4-N-acetyl-galactosaminyltransferase 3; Beta-1,4-N-acetylgalactosaminyltransferase III; beta4GalNAcT3; Beta4GalNAc-T3; N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N- acetylgalactosaminyltransferase; N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 2; NGalNAc-T2 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
283358 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin) | |
0.2 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
Q6L9W6 | |
B4GALNT3 | |
Recombinant protein corresponding to Human B4GALNT3. Recombinant protein control fragment (Product #RP-90289). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction